A. Rudresha, S. Hassan, A. Sreevalli, D. Lokanatha, M. Babu, K. Lokesh, L. Rajeev, S. Saldanha, A. Thottian, K. Sharma, L. Jacob
{"title":"缓解弥漫性大B细胞淋巴瘤第一周期效应的前期策略","authors":"A. Rudresha, S. Hassan, A. Sreevalli, D. Lokanatha, M. Babu, K. Lokesh, L. Rajeev, S. Saldanha, A. Thottian, K. Sharma, L. Jacob","doi":"10.1186/s43046-022-00116-5","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":17301,"journal":{"name":"Journal of the Egyptian National Cancer Institute","volume":" ","pages":""},"PeriodicalIF":2.1000,"publicationDate":"2022-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pre-phase strategy to mitigate first cycle effect in diffuse large B cell lymphoma\",\"authors\":\"A. Rudresha, S. Hassan, A. Sreevalli, D. Lokanatha, M. Babu, K. Lokesh, L. Rajeev, S. Saldanha, A. Thottian, K. Sharma, L. Jacob\",\"doi\":\"10.1186/s43046-022-00116-5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":17301,\"journal\":{\"name\":\"Journal of the Egyptian National Cancer Institute\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2022-05-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the Egyptian National Cancer Institute\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1186/s43046-022-00116-5\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Egyptian National Cancer Institute","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s43046-022-00116-5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
期刊介绍:
As the official publication of the National Cancer Institute, Cairo University, the Journal of the Egyptian National Cancer Institute (JENCI) is an open access peer-reviewed journal that publishes on the latest innovations in oncology and thereby, providing academics and clinicians a leading research platform. JENCI welcomes submissions pertaining to all fields of basic, applied and clinical cancer research. Main topics of interest include: local and systemic anticancer therapy (with specific interest on applied cancer research from developing countries); experimental oncology; early cancer detection; randomized trials (including negatives ones); and key emerging fields of personalized medicine, such as molecular pathology, bioinformatics, and biotechnologies.